SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-20-001500
Filing Date
2020-03-16
Accepted
2020-03-16 06:51:47
Documents
76
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2240891z10-k.htm 10-K 1257744
2 EX-4.6 a2240891zex-4_6.htm EX-4.6 57049
3 EX-21.1 a2240891zex-21_1.htm EX-21.1 4675
4 EX-23.1 a2240891zex-23_1.htm EX-23.1 4481
5 EX-31.1 a2240891zex-31_1.htm EX-31.1 11927
6 EX-31.2 a2240891zex-31_2.htm EX-31.2 12345
7 EX-32.1 a2240891zex-32_1.htm EX-32.1 12228
  Complete submission text file 0001047469-20-001500.txt   6739251

Data Files

Seq Description Document Type Size
8 EX-101.INS lptx-20191231.xml EX-101.INS 1541166
9 EX-101.SCH lptx-20191231.xsd EX-101.SCH 48550
10 EX-101.CAL lptx-20191231_cal.xml EX-101.CAL 59711
11 EX-101.DEF lptx-20191231_def.xml EX-101.DEF 167939
12 EX-101.LAB lptx-20191231_lab.xml EX-101.LAB 487112
13 EX-101.PRE lptx-20191231_pre.xml EX-101.PRE 366934
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Filer) CIK: 0001509745 (see all company filings)

IRS No.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37990 | Film No.: 20715216
SIC: 2834 Pharmaceutical Preparations